Castle Biosciences Inc (CSTL)

CapEx to Revenue

8.35%

Quarterly · Period ending:

CSTL logo

CSTL CapEx to Revenue

Latest reported8.35%
CSTL Quarterly CapEx/Revenue (0.78% → 8.35%)
High-resolution chart · PNG

CSTL capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
8.3538%
14.8843%
8.2565%
17.863%
10.7474%
5.3871%
8.7671%
7.4351%
6.0102%
12.5415%
5.7365%
3.9923%
8.0478%
7.9406%
4.6612%
5.5065%
4.033%
1.4971%
3.5664%
3.9489%
4.0118%
3.2876%
3.4048%
12.5255%
13.8105%
2.8706%
1.9697%
1.1181%
1.6841%
2.7948%
0.0474%
2.3442%
3.9209%
0.7813%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.